Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.345
Peer-review started: June 8, 2023
First decision: July 10, 2023
Revised: July 20, 2023
Accepted: August 21, 2023
Article in press: August 21, 2023
Published online: September 20, 2023
Processing time: 103 Days and 18.2 Hours
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the second leading cause of cancer-related deaths. Transcatheter arterial chemoembolization (TACE) is a therapy where drugs aimed to slow or halt tumor development are injected into the artery supplying for HCC tissues. A comprehensive analysis of all the articles on TACE for HCC can give us a general understanding of the progress in this field and provide guidance for future research.
The bibliometric analysis can be an important tool to help quantify and evaluate productivity within a scientifc feld, while also providing a comprehensive overview of the literature for students, trainees and experts in addition to identifying potential future research directions.
The aim of this study was to systematically analyze studies on TACE for HCC to determine its current status and assess future trends.
The “Web of Science” database was used to identify articles regarding TACE for the treatment of hepatocellular carcinoma (HCC) from 2012 to 2021. VOSviewer and CiteSpace were used to analyze the publications trends, collaboration between countries/institutions/authors, and the co-occurrence of keywords, keyword bursts, and references.
A total of 5728 original articles on TACE for HCC were retrieved. Regarding the volume of publications, the total number of yearly publications showed a generally increasing trend. China had the highest number of articles, while the United States achieved the highest Hirsch index and highest number of citations. The Sun Yat-sen University in China was most prolific institution. The most active author was Park JW from South Korea. The Journal of Vascular and Interventional Radiology (234 articles) was the most productive journal. There is a growing trend toward international collaboration in TACE for HCC. Cluster networks of co-cited references suggested that practice guidelines and targeted therapies are an essential theme in this field. In addition, cluster analysis based on keyword co-occurrence identified the research topic "prediction of TACE treatment" as a hotspot, and propensity score matching can be used to help investigators conduct innovative studies in the future.
We found that current research in this field focuses on survival prediction and TACE-based combined therapies. These results can also help researchers in the field find relevant literature and stay informed about hot topics.
High-quality international multicenter studies are needed to confirm how TACE-based combination therapies better improve patient survival.